Issue 38, 2025, Issue in Progress

Cumingianols G and H, new 14,18-cycloapoeuphane triterpenoids from the Taiwan Dysoxylum cumingianum C. DC.

Abstract

Two new 14,18-cycloapoeuphane triterpenoids, cumingianols G (1) and H (2), along with 12 known compounds, cumingianol C (3), cumingianol A (4), cumingianol D (5), 3,3-ethylenedioxy-5α-cycloart-24-en-23-one (6), 24,25(R,S)-24,25-epoxy-20(S)-hydroxydammar-3-one (7), (3β,7α)-stigmast-5-ene-3,7-diol (8), 7α-hydroxystigmasterol (9), 7β-hydroxysitosterol (10), 7β-hydroxystigmasterol (11), ethylcholest-5-en-3-hydroxy-7-one (12), coniferaldehyde (13) and 4-hydroxy-3,5-dimethoxy-benzaldehyde (14), have been isolated from Dysoxylum cumingianum collected in Taiwan. The structures of these metabolites were determined through mass spectrometry and 1D and 2D NMR analyses, combined with comparisons to reference data. The cytotoxic effects of these isolates were evaluated against human oral squamous cell carcinoma (SCC2095), human breast adenocarcinoma (MCF-7), and human gastric adenocarcinoma (SCM-1). Among them, compound 4 exhibited significant cytotoxicity against the SCC2095 and MCF-7 cell lines, with IC50 values of 6.3 μM and 6.1 μM, respectively.

Graphical abstract: Cumingianols G and H, new 14,18-cycloapoeuphane triterpenoids from the Taiwan Dysoxylum cumingianum C. DC.

Supplementary files

Article information

Article type
Paper
Submitted
27 May 2025
Accepted
22 Jul 2025
First published
01 Sep 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 31154-31161

Cumingianols G and H, new 14,18-cycloapoeuphane triterpenoids from the Taiwan Dysoxylum cumingianum C. DC.

T. H. Huynh, B. Peng, C. Tai, Y. Hung, Y. Su, J. Hu, J. Lee, C. Duh and J. Weng, RSC Adv., 2025, 15, 31154 DOI: 10.1039/D5RA03726C

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements